Sir, The endocardial disease associated with idiopathic eosinophilia was first appreciated by Loffler [1] in 1936. Since then, numerous reports and small series of patients have firmly established the association of these findings. [2, 3] Indeed, cardiovascular disease has been recognized as the major cause of morbidity and mor tality in patients with idiopathic eosinophilia. [4] Idiopathic hypereosinophilic syndrome is a rare systemic disease than can cause multiple organ failure by eosinophilic infiltration. Cardiac involvement is characterized by endocardial fibrosis and overlying thrombus, leading to restrictive cardiomyopathy and valvular dysfunction. Surgical experience of patients with mitral dysfunction caused by this syndrome is limited, and valvular replacement is most often performed. [5] Rheumatic heart disease is the commonest cause for valvular heart disease and hence most patients are empirically labeled with this diagnosis. However, routine preoperative evaluation revealed hyper eosinophilia in three patients forcing a re-consideration of their etiology.
Three patients (two males and one female) in age group (18-35 years) were evaluated for exer tional dyspnoea. Echocardiography revealed MS, MR with AS. The AR in two patients and MR in one patient. The patient with only MR also had a neurological deficit. The CT Brain revealed a parietal infarct. Hyper eosinophilia was seen in all patients ranging from 2 to 22 x 10 10 l -1 . Bone marrow revealed eosinophilia with normal cytogenetics. Ultrasound revealed mild splenomegaly in one patient. All three had elevated IgE levels. Connective tissue and malignancy workup was negative in all three. Two patients responded to steroids whereas the third required hydroxyurea and vincristine to control the eosinophilia. Two patients underwent double valve replacement and one had MVR. The valves used for replacement were StarrEdwards and St. Jude valves, respectively. Surgery was uneventful. The HPE revealed myxoid changes with focal aggregates of lymphocytes in two patients. One patient who had MVR with Starr-Edwards valve was readmitted 8 months later with a left ventricular clot with an intact valve. The other two patients are alive and well on follow up.
Harley et al. in an analysis of a large population of patients with the idiopathic hypereosinophilic syndrome defines two patterns of clinical illness with respect to the development of heart disease. In one pattern, hear t disease was accompanied by characteristics of a primary myeloproliferative type disease. [4] In the other pattern, patients remained free of hear t disease, the characteristics were more of allergic or hypersensitivity process. They tended to have elevated Ig, especially IgE, and elevated level of circulating immune complexes. [4] In our report on three patients, one had splenomegaly, and all three had elevated IgE levels, with two patients showing a dramatic response to steroids. Abnormal eosinophil morphology or eosinophilic infiltration of valves was not demonstrable in any patient. There was no evidence of rheumatic activity on Histopathological examination of the valves or in the blood tests. In our country where Rheumatic heart disease is the most common cause for valvular heart disease other causes such as eosinophilic myocarditis needs to be actively looked for before labeling a patient. A larger number of patients would fur ther emphasize this point.
